The groundbreaking success of Viagra undeniably reshaped the drug landscape, but investing in companies primarily reliant on off-patent versions presents a complex picture. Although early earnings were substantial, https://pharma458094.blogunteer.com/40514550/sildenafil-and-pharma-a-risky-bet